Advanced search
Publication Cover
Vascular Health and Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
124
Views
3
CrossRef citations to date
0
Altmetric
Review

New developments in atherosclerosis: clinical potential of PCSK9 inhibition

Ilaria GiunzioniKnight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University, Portland, OR, USACorrespondence[email protected]
&
Hagai TavoriKnight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University, Portland, OR, USA
Pages 493-501 | Published online: 24 Aug 2015

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ida Gregersen, Sverre Holm, Tuva B Dahl, Bente Halvorsen & Pål Aukrust. (2016) A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases. Expert Review of Cardiovascular Therapy 14:3, pages 391-403.
Read now

Articles from other publishers (2)

Frederick R. Maxfield. 2016. Lysosomes: Biology, Diseases, and Therapeutics. Lysosomes: Biology, Diseases, and Therapeutics 87 100 .
Harvey Wong & Matthew R. Wright. (2016) Pharmacokinetic considerations of antibody therapeutics. Biopharmaceutics & Drug Disposition 37:2, pages 49-50.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.